L-asparaginase for the treatment of cancer.
D001215:Asparaginase / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D001215:Asparaginase